Optimal use of pegfilgrastim (a long-acting granulocyte-colony stimulating factor [G-CSF]) to manage chemotherapy-induced febrile neutropenia (FN) in haematological malignancies: consensus guidance recommendations. (February 2017) - Aapro, M.; Boccia, R.; Choquet, S.; Hus, I.; Link, H.; Sliwa, T.